SCHEMBL6707727

SCHEMBL6707727

O=C(Nc1ccc(Br)cc1-c1noc(=O)[nH]1)c1noc2ccc(-c3ccccc3C(F)(F)F)cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.37
KMT2A Q03164 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
TSHR P16473 2/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
XBP1 P17861 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
EPHX2 P34913 1/20 0.36
ROCK1 Q13464 1/20 0.36
KIT P10721 1/20 0.35
KDR P35968 1/20 0.35
FLT3 P36888 1/20 0.35
USP2 O75604 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709925 0.94 EPHX2 (0.41) GRIK1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL6711801 0.90 HIF1A (0.43) GRIK1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL6710018 0.89 DHODH (0.39) GRIK1KMT2ASMN1; SMN2MEN1ROCK1
SCHEMBL6709967 0.88 CETP (0.35) KMT2ASMN1; SMN2NPC1RAB9ATSHR
SCHEMBL6711725 0.87 HIF1A (0.45) GRIK1KMT2AMEN1NPSR1ROCK1
SCHEMBL6711582 0.86 KMT2A (0.36) KMT2ASMN1; SMN2NPC1RAB9ATSHR
SCHEMBL6709887 0.85 GRIK1 (0.43) GRIK1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL6709153 0.84 EPHX2 (0.43) GRIK1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL6709940 0.83 HIF1A (0.51) GRIK1ROCK1HIF1A
SCHEMBL6707809 0.82 EPHX2 (0.40) KMT2ASMN1; SMN2NPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885KMT2A 3181/4885SMN1; SMN2 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.